BioCentury
ARTICLE | Emerging Company Profile

Scenic: targeting genetic modifiers to suppress disease drivers

Emerging Company Profile: Amsterdam-based Scenic is developing small molecules against genetic modifiers for metabolic and inflammatory rare diseases, cancer

June 15, 2021 5:38 PM UTC


Access this Article

BCIQ Company Profiles

Scenic Biotech B.V.